Skip to main content
Clinical Trials/NCT01913288
NCT01913288
Unknown
Not Applicable

Exposure to Biological Maternal Sounds in Extremely Preterm Infants: Effects on Short- and Long-term Outcomes

Brigham and Women's Hospital1 site in 1 country150 target enrollmentMay 2013
ConditionsPreterm Birth

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preterm Birth
Sponsor
Brigham and Women's Hospital
Enrollment
150
Locations
1
Primary Endpoint
Brain volume (DM^3)
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this RCT is to learn more about how sounds that we experience in the womb can affect early development in premature infants. The investigators are specifically interested determining whether and what types of maternal sensory stimulation can influence physical growth, brain maturation, respiratory stability and early vocalization during postnatal development. The investigators hypothesize that daily exposure to biological maternal sounds, such as mother's voice and heartbeat, will improve both short-term and long-term developmental in premature infants and will increase their potential to grow into healthy children.

Detailed Description

The purpose of this RCT is to learn more about how sounds that we experience in the womb can affect early development in premature infants. The investigators are specifically interested determining whether and what types of maternal auditory stimulation can influence physical growth, brain maturation, respiratory stability (including heart rate, respiratory rate and oxygen saturation levels) as well as early vocalization prior to 40 weeks gestation. The investigators hypothesize that daily exposure to biological maternal sounds, such as mother's voice and heartbeat, will improve both short-term and long-term developmental outcomes in premature infants and will increase their potential to grow into healthy children.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
December 2019
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amir Lahav

Instructor in Pediatrics

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Born between 24-36 weeks GA.

Exclusion Criteria

  • Chromosomal or congenital anomalies; congenital infections; \> grade II IVH;
  • maternal use of tobacco, alcohol, or illicit drugs;
  • significant abuse or malnutrition during pregnancy,
  • failed ABR.
  • No exclusions based on gender or ethnicity.

Outcomes

Primary Outcomes

Brain volume (DM^3)

Time Frame: Between 36-40 weeks gestation

Data will be obtained by an MRI brain scan and will be calculated separately for white matter, grey matter, CSF.

Language and cognitive skills

Time Frame: At 12 and 24 months corrected-age

Data will be obtained using the MacArthur-Bates Communicative Development Inventories (CDI), the Receptive-Expressive Emergent Language Test Third Edition (REEL-3), and the Bayley Scales of Infant Development Third Edition (Bayley-III).

Secondary Outcomes

  • Oxygen saturation levels (mg/l)(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)
  • Heart rate (BPM)(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)
  • Infant vocalization (word count)(Between 32-36 weeks gesation)
  • Weight gain (gr/kg/day)(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)

Study Sites (1)

Loading locations...

Similar Trials